Home » Alkermes Is Encouraged by Drug Data
Alkermes Is Encouraged by Drug Data
Alkermes Inc. announced “positive preliminary results” from a phase 3 clinical trial
of its drug Vivitrol for the treatment of opioid dependence.
boston
boston
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May